Interim report
Page 1
ICONOVO QUARTERLY REPORT Q2 2026 | 20 August 2026 Single - dose 1 Inhaler dose ICOone® ICONOVO ICONOVO ICOresⓇ Multi - dose Dual reservoir Inhaler 180doses ICOcap® Capsule Inhaler ICONOVO PRODUCT NAME Muticasone furoate 0mcg and vilanterol mcg inhalation powder ) mcg / 25 mcg ORAL INHALATION ONLY pened : ( 6 weeks ) : XXXXXXX barcode 1 Product Name Inhaler holding 30 doses ( 60 containers total ) ICONOVO Nasal Powder dose ICOone® ICONOVO " Strong focus on securing out - licensing agreements for the generic products based on Ⓡ ICOres and ICOpreⓇ . " Anders Månsson , CEO 1